Recognizing the Giants

Mike Hennessy
Published: Saturday, Jun 07, 2014
Mike Hennessy

OncLive Chairman,
Mike Hennessy

This month marks a happy anniversary for OncologyLive and the entire Intellisphere® Oncology Specialty Group.

We are pleased to present the second class of leading oncology specialists whom an esteemed advisory board has chosen to honor with our 2nd Annual Giants of Cancer Care™ awards.

Indeed, we feel a sense of privilege to have this opportunity to recognize individuals whose talent and dedication has improved the lives of countless patients.

As oncology information service providers, we are continually impressed by the level of commitment that the entire oncology community brings to the challenging spectrum of care that patients diagnosed with this devastating disease require.

Like so many Americans, many of us have been personally affected by cancer through the experiences of a friend or loved one. We know about that dedication firsthand.

We have made it a corporate priority to salute those who have contributed so richly to the remarkable progress against cancer currently under way.

In 2013, the inaugural Giants awards celebrated the achievements of 12 researchers whose discoveries have propelled the field forward and established the building blocks for future advances.

This year, we expanded the field to include 16 winners, 11 of whom were recognized for their innovations regarding particular tumor types and five who were honored in specialty categories.

We are showcasing these winners in this issue of OncologyLive. In the coming months, we will describe their achievements and their personal journeys in greater detail. Testimonials from fellow researchers and colleagues will be included in our publications and on our website, OncLive.com.

In June, the advisory board that chose these winners will announce a Pioneer honoree—an individual who has already accomplished his or her most notable contributions.

We invite you to join in the conversation about the impact that advances promulgated by these Giants have had on your ability to help patients. As always, thank you for reading.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x